Abstract: An efficient, sensitive spectrophotometric method has been developed and validated for the determination of bromhexine hydrochloride (BRH), in bulk drug and its pharmaceutical formulations. The method is based on the formation of Schiff Base with paradiethylamminobenzaldehyde (PDEAB) the reaction of drug with reagent gives a bright yellow colour. The so formed coloured species absorbance was measured at its absorption maximum (λ max ) 425 nm. The Beer's law has been obeyed in the concentration range 2-20 µg/mL. The optical parameters were calculated as 2.42918x10 4 L/mol/cm, 0.016985 µg/cm 2 , molar absorptivity and Sandell's sensitivity respectively. The LOD and LOQ of the proposed method were calculated 0.2011 µg/mL, 0.6696 µg/mL respectively. All the variables were studied to optimize the reaction conditions. No interference was observed in the presence of common pharmaceutical excipients. The validity of the method was tested by analyzing BRH in its pharmaceutical formulations and critically tested for its accuracy by statistical tests. Good recoveries were obtained by the developed method; the obtained results were critically analyzed and successfully employed for the determination of BRH in its pharmaceutical dosage forms.
Introduction
Bromhexine HCl (BRH), chemically named 2-amino-3,5-dibromo-N-cyclohexyl-N-methyl benzenemethanamine hydrochloride (Figure 1 ), is a mucolytic agent used in the treatment of respiratory disorders associated with viscid or excessive mucus. This agent's mechanism is to increase the production of serous mucus in the respiratory tract and it makes the phlegm thinner and less viscous. BRH is a mucous modifying drug that helps to improve the flow properties of bronchial mucous and eases expectoration 1, 2 . The drug is official in IP 3 and BP 4 .
Because of its physiological importance, the drug has been quantified by exploiting its chemical 5, 6 and physical properties [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] . The different analytical methods used to quantify the drug as a single active pharmaceutical ingredient include flow injection analysis with ion RESEARCH ARTICLE selective electrodes 7 , inductively coupled plasma mass spectrometry 8 , electrokinetic chromatography 9 , electrochemical oxidation at the glassy carbon electrode 10 , liquidchromatography 11 , liquid gas chromatography 12 , GC with mass detection 13 and voltammetry 14 .
The drug has also been quantified in its combined formulations using HPLC [15] [16] [17] [18] , direct and derivative UV spectrophotometry [19] [20] [21] [22] [23] . These methods involve scarcely available costly equipment and tedious experimentation.
Simple, accurate and precise methods using spectrophotometry have also been developed based on the production of chromophore by the interaction of the drug with an analytical reagent, as chromogen [24] [25] [26] . Availability of vast number of analytical reagents to serve as chromogens always leaves a lot of scope for pharmaceutical analysis. A thorough survey of the literature showed that the quantification methods of our interest are not reported yet and hence in the present communication we report a quantification method that has been developed and validated for quantification of bromhexine HCl both in pure and pharmaceutical dosage forms. In the present research work an effort has been made to develop and validate a simple spectrophotometric determination of BRH in bulk and pharmaceutical formulations. Although there are several highly sophisticated instrumental methods were reported but are suffered by time of analysis, cost per analysis, sophistication and most importantly the skilled analyst to handle the instruments. The present method offers a simple, sensitive, cost effective method for the determination of BRH in any common QC laboratory. 
Experimental
Spectral and absorbance measurements were carried out by using double beam UVspectrophotometer ELICO-SL-244.
Materials and reagents
All the chemicals used were of analytical grade. All the solutions were prepared freshly and deionised water was used throughout the experiment. Ambroxol hydrochloride bulk drug obtained from sun pharmaceutical (Mumbai, India) certified to contain 99.5% of active ingredient, which has been used as a reference substance, as received without further purifications. Sublimed iodine was procured from Sd-Fine chemicals 99.5% purity and HCl procured from Sd-Fine chemicals 35% purity. Methanol AR grade procured from Sd-Fine chemicals.
Bromhexine hydrochloride tablets were purchased from pharmaceutical store, different makes such as Ascoril® (8 mg BRH) and TusQ® (8 mg BRH) from Glenmark (India) laboratory Ltd. and Blue Cross Laboratory Ltd. respectively.
Preparation of standard stock solution
10 mg of the reference standard was accurately weighed and transferred in to a 10 mL volumetric flask, 5 mL of deionised water was swirled to mix and brought to the mark with deionised water. The apparent concentration has been reached to 1000 µg/mL further stepwise dilutions were made to obtain the working standard stock solution 100 µg/mL.
Preparation of sample solution
i) Ascoril® tablets (15 tablets) labelled claim to contain 8 mg of BRH, average weight of each tablet was 420 mg were triturated and made a fine powder, mixed it well for homogeneity. A portion (5250 mg) of the fine powder was transferred to contain 100 mg of the BRH in to a beaker and dissolved with 20 mL of deionised water and mixed well. This solution was filtered through a Whatmann filter paper No.41, in to a 100 mL volumetric flask. The filtrate was made up to the mark with deionised water. ii) TusQ® tablets (15 tablets) labelled claim to contain 8 mg of BRH, average weight of each tablet was 550 mg were triturated and made a fine powder, mixed it well for homogeneity. A portion (6875 mg) of the fine powder was transferred to contain 100 mg of the BRH in to a beaker and dissolved with 20 mL of deionised water and mixed well. This solution was filtered through a Whatmann filter paper No.41, in to a 100 mL volumetric flask. The filtrate was made up to the mark with deionised water.
General procedure for the determination of bromhexine hydrochloride
Variable aliquots of working standard solution containing 2-20 µg/mL of BRH were transferred in to series 10 mL volumetric flasks. To each flask 1 mL of concentrated HCl was added, mixed the solution mechanically followed by added 2 mL of 2% PDEAB solution, heated the contents on water bath at 70 ºC for 5 min then there was the formation of yellow coloured Schiff base. The yellow coloured species absorbance was measured at 425 nm using reagent as a blank. The formation of Schiff base was shown in Scheme 1. The calibration graph was prepared by plotting absorbance versus concentration of drug and the concentration of unknown was read from the calibration graph or computed from the regression equation derived from the Beer's law data. The same procedure was followed for the determination of BRH in the tablet formulations and the content of the tablets were calculated by using regression equation.
Scheme 1

Results and Discussion
Determination of absorption maxima (λ max )
To determine the λ max of the coloured species, 1 mL of 100 µg/mL of the BRH was added to a 10 mL volumetric flask and 1 mL of concentrated HCl, mixed the contents mechanically then added 2 mL of 2% PDEAB solution, heated the contents on water bath at 70 ºC for 5 min then there was the formation of yellow coloured Schiff base. The flasks are allowed to cooled to room temperature and the solutions was made up to the mark with water. The coloured species was measured against reagent blank in the range of 350 nm to 900 nm. The λ max of the complex was found to be 425 nm. Absorption spectrum of the proposed method was shown in Figure 2 . Under the experimental conditions each reagent blank showed a negligible absorbance at the corresponding λ max. 
Investigation of assay parameters
Optimum reagent concentrations required for the formation of sensitive and quantitative coloured products were determined by varying one reagent concentration and fixing the concentrations of other reagents and its effect on absorbance was measured at 425 nm.
Effect of heating time
To study the effect of heating time for the development of maximum colour, the contents of the mixture were heated for up to 20 min. at 70±1 °C. The intensity of the colour developed was measured at room temperature after the dilution to 10 mL with deionised water. It is apparent from the investigation that the maximum intensity of colour was obtained after 5 min of heating and remained constant. Therefore the optimum heating time was fixed to 5 min.
Effect of reagent concentration
The effect of concentration of PDEAB solution and HCl were studied on the related absorbance values. Different concentrations of PDEAB solutions from 0.5% to 5% were studied. Volumes of 0.5-3.0 mL of PDEAB (2%) and 0.5-3.0 mL of concentrated HCl were examined. The investigations showed that 2.0 mL of PDEAB and 1.0 mL of concentrated HCl Wavelength, nm Absorbance gave maximum absorbance. There is no change in intensity of the colour any further with the increasing amounts of PDEAB and concentrated HCl. So the 2.0 mL of PDEAB and 1.0 mL of concentrated HCl were chosen throughout the experiment.
Interference studies
To study the potential interference from the commonly used excipients and other additives such as glucose, lactose, starch, sodium starch glycolate, cellulose, magnesium stearate and ascorbic acid recovery studies were carried out. Under the experimental conditions employed, to a known amount of drug. The recovery studies suggest that there was no significant interference from the excipients on the assay of the drug.
Validation of the method
Detection and quantification limits
According to the analytical methods committee the detection limit (LOD) is the concentration of drug corresponding to a signal equal to the blank mean (Y B ) plus three times the standard deviation of the blank (S B ). Quantification limit (LOQ) is the concentration of drug corresponds to the blank mean plus ten times the standard deviation of the blank. The LOD and LOQ values for BRH were found to be 0.2011 µg/mL and 0.6696 µg/mL respectively 27 .
Quantification
The optical characteristics such as Beer's law limits, Sandell's sensitivity and molar absorptivity were calculated for the proposed method and the results are summarized in Table 1 . Regression analysis of the Beer's law plot at their λ max revealed a good correlation as shown in Figure 3 . For the regression analysis we have selected different concentration sets but the best fit curve was obtained in the concentration range 2 to 20 µg/mL of standard BRH. For the verification of Beer's law we have taken a series of 10 mL volumetric flasks and added the working standard solution (100 µg/mL) serially from 0.2 mL to 2.0 mL followed by added all the reagents as mentioned in the assay procedure. Graph of absorbance versus concentration plotted and are described by the regression equation Y= bx+a (where 'Y' is the absorbance, 'b' is the slope, 'x' is the concentration of the drug in µg/ml and 'a' is the intercept) obtained by least squares method [28] [29] [30] . The results were summarized in Table 1 . 
Accuracy precision and recovery studies
The accuracy and precision of the proposed method was evaluated by performing five replicate determination of BRH in pure form at three different concentrations (5, 11 and 17 µg/mL) by short term (intra-day) precisions as shown in Table 2 . The standard analytical errors, relative standard deviations (%RSD) and recoveries obtained in the intra-day analysis for the proposed method were found to be acceptable. Thus the proposed method is effective for the determination of BRH. 
* For five determinations
The accuracy of the proposed method was further checked by performing recovery experiments through standard addition technique. For this purpose, a known amount of pure BRH was added to pre-analyzed dosage forms and then determined by the recommended procedure. The results are as shown in Table 3 . The values of mean recovery and relative standard deviation (%RSD) were in the range of 99.75-99.98% and 0.207-0.301% respectively. This indicates the reproducibility of the method. No interference was observed from the common excipients of tablet.
Applicability of the method
The proposed method applied to the analysis of BRH in pharmaceutical dosage forms and the results were statistically compared with reference method by calculating the student's 
Conclusion
The proposed method was quite simple and do not require any pre-treatment of the drug and tedious extraction procedure. The method has a wider range with good accuracy and precision. Hence, the data presented in the manuscript demonstrate that the proposed method was accurate, precise, linear, selective and offers advantages of reagent availability and stability, less time consumption and highly sensitive. Thus it can be extended for routine analysis of BRH in pharmaceutical industries and hospitals and research laboratories. Unlike the LC/MS procedure and HPLC procedures, the UV-Visible spectrophotometer instrument is simple and not of highly expensive on the other hand in simplicity and user friendly the method could be considered superior in comparison with the previously reported methods. Moreover the method is free from interferences by common additives and excipients.
